Evidence map›Paper›PMID 36414955›Full record

ArticleBMC public health2022

Barriers and facilitators to cervical cancer screening among under-screened women in Cuenca, Ecuador: the perspectives of women and health professionals.

Bernardo Vega Crespo, Vivian Alejandra Neira, José Ortíz Segarra, Andrés Andrade, Gabriela Guerra, Stalin Ortiz, Antonieta Flores, Lorena Mora, Veronique Verhoeven, Ana Gama and 5 more

Abstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. High frequency of HPV high-risk preventable genotypes in Ecuadorian women with invasive cervical cancer.Revista panamericana de salud publica = Pan American journal of public health · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bernardo Vega CrespoFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador. bernardo.vegac@ucuenca.edu.ec.
Vivian Alejandra NeiraFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
José Ortíz SegarraFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
Andrés AndradeFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
Gabriela GuerraFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
Stalin OrtizFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
Antonieta FloresFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
Lorena MoraFacultad de Ciencias Médicas, Universidad de Cuenca, 010203, Cuenca, Ecuador.
Veronique VerhoevenFamily Medicine and Population Health, University of Antwerp, 2610, Antwerp, Belgium.
Ana GamaNOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, 1169-056, Portugal.
Sónia DiasNOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, 1169-056, Portugal.
Bo VerberckmoesInternational Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, 9000, Belgium.
Heleen VermandereInternational Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, 9000, Belgium.
Kristien MichelsenInternational Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, 9000, Belgium.
Olivier DegommeInternational Centre for Reproductive Health (ICRH), Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, 9000, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer screening is a cost-effective method responsible for reducing cervical cancer-related mortality by 70% in countries that have achieved high coverage through nationwide screening strategies. However, there are disparities in access to screening. In Ecuador, although cervical cancer is the second most common cancer in women, only 58.4% of women of reproductive age have ever been screened for cervical cancer. METHODOLOGY: A qualitative study was performed to understand the current barriers to screening and to identify strategies that could increase uptake in Azuay province, Ecuador. Seven focus group discussions (FGDs) were conducted with under-screened women and health professionals (HPs). The FGDs were recorded and transcribed. Content analysis was done using the socio-ecological framework to categorize and analyse the data.

resultsOverall, 28 women and 27 HPs participated in the study. The two groups perceived different barriers to cervical cancer screening. The HPs considered barriers to be mainly at the policy level (lack of a structured screening plan; lack of health promotion) and the individual level (lack of risk perception; personal beliefs). The women identified barriers mainly at organizational level, such as long waiting times, lack of access to health centres, and inadequate patient-physician communication. Both groups mentioned facilitators at policy level, such as national campaigns promoting cervical cancer screening, and at community and individual level, including health literacy and women's empowerment.

conclusionsThe women considered access to health services the main barrier to screening, while the HPs identified a lack of investment in screening programmes and cultural patterns at the community level as major obstacles. To take an integrated approach to cervical cancer prevention, the perspectives of both groups should be taken into account. Additionally, new strategies and technologies, such as self-administered human papillomavirus (HPV) testing and community participation, should be implemented to increase access to cervical cancer screening.

Indexed as

Early Detection of CancerUterine Cervical NeoplasmsEcuadorFemaleHumansMass ScreeningPatient Acceptance of Health CareBarriers and facilitatorsCervical cancerEcuadorHPVScreening

Identifiers

PMID36414955
PMCPMC9682802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.